View Author
Rickinson, A.B.
( A.B. Rickinson)
patient ebv-specific ebv reactivation reactivation t-cell ebv-lpd blood month recipient recovery time point epitope transplantation 1000 geq /ml virus donor number lytic epstein-barr 6 months graft cell transplantation study tetramer lymphocytes marrow epstein-barr virus 3 months figure response disease value range ebv-specific t cells allogeneic point level sct recipients lymphoproliferative t-celldepleted ebv load t-celldepleted sct result development bone marrow transplant *0201 sample table panel sct donor *3501 infection reconstitution antigen cell grafts plasma time interval interval posttransplant lymphoproliferative disease protein *0702 repopulation 50 geq /ml detection subset assay bone marrow transplantation allele treatment proportion group kinetic analysis t cells *0801 tetramer technology erasmus mc control count volume
1 Most Recent Publications
|
Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease
(Article)
Meij, P. Löwenberg, B. Leiner, I. Pamer, E. Gratama, J-W. Cornelissen, J.J. Esser, J.W.J. van Niesters, H.G.M. Baarle, D. van Miedema, F. Blake, N. Rickinson, A.B. |
2003-01-01
|
